Steris | Rövid Lejáratú Kötelezettségek



Current Liabilities változás Dátum
3M USD 11.26B 135M 2024-12
Avanos Medical USD 165.9M 47M 2024-12
Baxter International USD 6.51B 311M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Boston Scientific USD 6.4B 489M 2024-12
CONMED USD 278.13M 4.18M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Ecolab USD 4.79B 83.7M 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Fortive USD 2.24B 137.6M 2024-12
Getinge SEK 15.05B 169M 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Haemonetics USD 253.23M 20.71M 2024-12
Hologic USD 1B 34.8M 2024-12
Idexx Laboratories USD 1.07B 58.69M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
J&J USD 50.32B 1.44B 2024-12
Masimo USD 617.7M 19.9M 2024-12
Olympus JPY 414.56B 5.02B 2024-12
Owens Minor USD 1.87B 60.43M 2024-12
ResMed USD 851.96M 52.12M 2024-12
Steris USD 891.12M 85.64M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Steris Rövid Lejáratú Kötelezettségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.